Evolent Health, Inc found using ticker (EVH) have now 8 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 57 and 32 and has a mean target at 42.25. Now with the previous closing price of 28.66 this indicates there is a potential upside of 47.4%. The 50 day moving average now sits at 29.85 while the 200 day moving average is 31.04. The company has a market capitalisation of $2,759m. You can visit the company’s website by visiting: https://www.evolenthealth.com
The potential market cap would be $4,068m based on the market concensus.
Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
